Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04552873Active, not recruiting
Randomised, double-blind trial of urea in hyponatremia (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Effectiveness of urea therapy in correcting persistent hyponatremia at 5 days. Started Dec 2020; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04552873.